IMPROVED TARGET BASE SUBSTITUTION BY MODIFIED LNA NUCLEOTIDES Russian patent published in 2012 - IPC C12N15/10 C12N15/11 C12N15/00 

Abstract RU 2463350 C2

FIELD: medicine.

SUBSTANCE: invention may be used for target modification of a duplex DNA (double straight DNA) sequence. What is presented is a donor oligonucleotide a sequence of which is complementary along its whole length to the modified acceptor DNA with the exception of one nucleotide forming a mispairing with the modified duplex DNA sequence describing the expected substitute. The oligonucleotide under the invention comprises two modified nucleotide which represent LNA, and spaced at one nucleotide from a mispairing point from both sides.

EFFECT: what is described is a method for effective modification of the duplex DNA sequence with the use of the new oligonucleotide; conditions and means required for implementation thereof are disclosed.

14 cl, 3 dwg, 1 ex

Similar patents RU2463350C2

Title Year Author Number
IMPROVED METHOD OF MUTAGENESIS WITH APPLICATION OF POLYETHYLENE GLYCOL-MEDIATED INTRODUCTION OF MUTAGENIC NUCLEIC BASES INTO PLANT PROTOPLASTS 2007
  • Bjundok Paul'
  • De Bot Mikhil Teodor Jan
  • Lejssir Frank
RU2515110C2
OLIGONUCLEOTIDES FOR MAKING CHANGE IN SEQUENCE OF TARGET RNA MOLECULE PRESENT IN LIVING CELL 2013
  • De Boer Deniel Anton
  • Ritsema Tita
RU2663110C2
COMPOSITIONS AND METHODS FOR MODIFICATION OF SPECIFIED TARGET NUCLEIC ACID SEQUENCE 2012
  • Shibolet Joel Moshe
  • Vejntal Dan Majkl
RU2663354C2
TREATMENT OF DISEASES ASSOCIATED WITH ERYTHROPOIETIN (EPO) BY NATURAL EPO ANTISENSE TRANSCRIPT INHIBITION 2009
  • Kollard Dzhozef
  • Khorkova Sherman Olga
RU2620970C2
TREATING SIRTIUN 1 (SIRT1)-RELATED DISEASES BY INHIBITON OF NATURAL ANTISENSE TRANSCRIPT 2009
  • Kollard, Dzhozef
  • Khor'Kova Sherman, Ol'Ga
  • Kojto, Karlush
  • De Leon, Belinda
RU2551234C2
OLIGONUCLEOTIDE CONJUGATES 2013
  • Albek Nanna
  • Khansen Khenrik Fryudenlunn
  • Kammler Syuzann
  • Ravn Yakob
  • Erum Khenrik
RU2653438C2
TREATING DISEASES ASSOCIATED WITH VASCULAR ENDOTHELIAL GROWTH FACTOR (VEGF) BY SUPPRESSION OF NATURAL ANTISENSE VEGF TRANSCRIPT 2009
  • Kollard Dzhozef
  • Khor'Kova Sherman Ol'Ga
RU2569182C2
OLIGOMER COMPOUND REDUCING EXPRESSION OF HUMAN GENE Bcl-2, CONJUGATE, PHARMACEUTICAL COMPOSITION AND APPLICATION OF OLIGOMER COMPOUND IN CANCER TREATMENT 2004
  • Freden Miriam
  • Khansen Jens Bo
  • Erum Khenrik
  • Vestergor Majken
  • Tru Sharlot Al'Behk
RU2377301C2
SYSTEM OF TARGETED SPLICING CHANGES IN MARK2 GENE 2023
  • Pervushin Dmitrij Davidovich
  • Skvortsov Dmitrij Aleksandrovich
  • Margasyuk Sergej Dmitrievich
  • Petrova Marina Viktorovna
  • Vlasenok Mariya Aleksandrovna
  • Zavilejskij Lev Georgievich
RU2810907C1
METHOD FOR CHANGING THE FUNCTIONAL STATE OF MRNA, WHICH ENABLES SELECTIVE AND SPECIFIC IDENTIFICATION THEREOF 2016
  • Razga Filip
  • Nemetgova Veronika
RU2724485C2

RU 2 463 350 C2

Authors

Bjundok Pol

De Bot Mikhil Teodor Jan

Khogers Rene Kornelis Jozefus

Vakhovskij Ljudvik Kevin

Dates

2012-10-10Published

2006-12-21Filed